Description
GENOMIC SEQUENCING IGF::OT::IGF
First action · last action
2015-09-30 · 2015-09-30
Transactions
1
First transaction's obligation
$247,656
Base + all options value (sum of deltas)
$247,656
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
2
SDVOSB flag on record
No
Parent IDV
VA24013D0053
NAICS
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-09-30+$247,656= $247,656
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-09-30 | +$247,656 | $247,656 | GENOMIC SEQUENCING IGF::OT::IGF |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UKTDBM9KX1V8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E26N0234 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $18,290,000 | FY2026 |
| 36C24E25N0228 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $13,500,000 | FY2025 |
| 36C24E25N0103 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $334,000 | FY2025 |
| 36C24E24N0268 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $7,499,947 | FY2024 |
| 36C24E23N0245 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $230,580 | FY2023 |
| 36C24E23N0192 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $7,499,520 | FY2023 |
Other recipients under R405 from 00268 PCA EAST (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26815J0195 | AZENTA US INC | 00268 PCA EAST | $3,749,955 | FY2015 |
| VA26815J0199 | CLARITAS GENOMICS, INC. | 00268 PCA EAST | $253,110 | FY2015 |
| VA26815J0196 | AKESOGEN, INC. | 00268 PCA EAST | $3,749,937 | FY2015 |
| VA26815J0107 | CLARITAS GENOMICS, INC. | 00268 PCA EAST | $12,000 | FY2015 |
| VA26815P0053 | ACADEMY HEALTH | 00268 PCA EAST | $35,000 | FY2015 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26815J0198_3600_VA24013D0053_3600 · retrieved 2026-09-26.